ArticleScientific reports2025
The Role of Aquaporin-4 in Freezing of Gait and Dynamic Balance Learning in Parkinson's Disease.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Aquaporin-4 (AQP4), a modulator of motor symptoms and synaptic plasticity, may contribute to freezing of gait (FOG)-a significant gait disturbance in Parkinson's disease with an unclear pathophysiology-and its associated impairments in balance learning. However, this potential relationship has not been investigated until now. This preliminary study explores the potential role of AQP4 in FOG and its associated balance learning deficits. The study involved fifteen patients with FOG, fifteen patients without FOG, and fifteen healthy controls. Serum AQP4 levels were measured using enzyme-linked immunosorbent assay, and balance learning was assessed using a voluntary dynamic balance task performed on a stabilometer. Notably, patients who were FOG-positive exhibited significantly higher serum AQP4 levels compared to the other two groups (p < 0.001). These elevated levels showed a positive correlation with FOG severity (ρ = 0.51, p = 0.004). Furthermore, the serum AQP4 levels were inversely correlated with both the slope (ρ = -0.65, p < 0.001) and rate (ρ = -0.46, p = 0.01) of balance learning in PwPD. FOG-positive individuals exhibited impaired voluntary balance learning compared to both FOG-negative and healthy participants. FOG-negative participants showed initial improvement, while healthy individuals demonstrated continuous enhancement across consecutive learning blocks (the first significant main effect of time on balance performance, comparing Blocks 1 and 2, was p = 0.02 for FOG-negative and p = 0.03 for healthy groups), with both groups maintaining their acquired skills over time. These findings suggest that AQP4 may play a significant role in FOG and its associated learning impairments, warranting further investigation for potential treatments. Additionally, alternative balance learning protocols may be necessary for FOG-positive patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.